RVPH – reviva pharmaceuticals holdings, inc. (US:NASDAQ)

News

Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum [Yahoo! Finance]
Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum
Reviva Pharmaceuticals (NASDAQ:RVPH) was upgraded by analysts at Wall St
Reviva Pharmaceuticals (NASDAQ:RVPH) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com